Today FAH submitted comments to three Cabinet Secretaries Xavier Becerra, Marty Walsh, and Janet Yellen (HHS, Labor, and Treasury, respectively) regarding a proposed rule to implement provider enforcement provisions under the No Surprises Act, which […]
Read More… from FAH Submits Comments on Surprise Billing Provider Enforcement Proposed Rule
In comments sent today to CMS and OMB on its information collection for developing an Inpatient Rehabilitation Facility (IRF) Review Choice Demonstration, FAH urged CMS to withdraw the proposed program that would require either 100 […]
Read More… from FAH Opposes IRF Review Choice Demo in Comments to CMS
WASHINGTON – FAH President and CEO Chip Kahn released the following statement after the Biden Administration issued an interim final rule with comment period to further implement the No Surprises Act: “The interim final regulation […]
Read More… from “Total Miscue” – FAH Leader Reacts to Release of Surprise Billing Regulation
In comments submitted today, FAH reiterated its full support for CMS’s prospective budget-neutral 340B payment policy to continue to pay Average Sales Price (ASP) minus 22.5 percent for 340B-acquired drugs. “We agree with CMS that […]
Read More… from FAH Comments on CY 2022 Medicare OPPS Proposed Rule
